Gladius Pharmaceuticals' Series A Round

Gladius Pharmaceuticals raised a round of funding on June 22, 2015.

Gladius Pharmaceuticals is a Montreal-based biotechnology firm developing novel drugs to treat life-threatening, multi-drug-resistant bacterial infections.…

Articles about Gladius Pharmaceuticals' Series A Round: